MOTHAFFAR RIMAWI to Cell Cycle
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Cell Cycle.
Connection Strength
0.019
-
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011 Oct; 129(3):819-27.
Score: 0.019